Infantile Epilepsy Panel, Sequence Analysis and Exon-Level Deletion/Duplication
Use to confirm a diagnosis of familial infantile epilepsy and inform patient management. May be used to test at-risk relatives of individuals with a known familial pathogenic variant or to identify a known familial pathogenic variant in an at-risk pregnancy.
Next Generation Sequencing
New York DOH Approval Status
Lavender (K2 or K3 EDTA). Also acceptable: Pink (K2EDTA).
Transport 5 mL whole blood. (Min: 2 mL)
Test is not performed at ARUP; separate specimens must be submitted when multiple tests are ordered.
Room temperature. Also acceptable: Refrigerated. Protect from extreme temperatures.
Clinical indication or reason for testing is required.
Ambient: 1 week; Refrigerated: 1 week; Frozen: Unacceptable
Performed by non-ARUP Laboratory
81404; 81405; 81406; 81407; 81185
|Component Test Code*||Component Chart Name||LOINC|
|2007536||Infantile Epilepsy Panel||35474-6|
|2010873||Ordering Physician Name||67102-4|
|2010874||Ordering Physician Phone Number||67714-6|
|2010887||EER Infantile Epilepsy Panel||11526-1|